Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 222

Sort by

Sort Order Select

Journal Articles

CircPCMTD1 : A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts

Dimitrios Papaioannou, MD, Remi Buisson, Andreas Petri, PhD, Allison Walker, Marius Bill, MD PhD, Felice Pepe, PhD, Deedra Nicolet, MS, Lauren A Woodward, Krzysztof Mrózek, MD PhD, Malith Karunasiri, Gregory K. Behbehani, MD PhD, Emanuele Cocucci, PhD, Guramrit Singh, PhD, Sakari Kauppinen, PhD, Adrienne M. Dorrance, PhD, Clara D. Bloomfield, MD, Ramiro Garzon, MD

Blood (2019) 134 (Supplement_1): 640.

https://doi.org/10.1182/blood-2019-126223

Published: 2019

Journal Articles

Cooperation between SYK and ZAP70 Kinases As a Driver of Oncogenic BCR-Signaling in B-Cell Malignancies

Teresa Sadras, PhD, Jevon Cutler, Julia Aguade-Gorgorio, PhD, Zhengshan Chen, MD PhD, Kadriye Nehir Cosgun, PhD, Akhilesh Pandey, MD PhD, Markus Muschen, MD

Blood (2018) 132 (Supplement 1): 3922.

https://doi.org/10.1182/blood-2018-99-116954

Published: 2018

Journal Articles

Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar

Mohamed Ismail, BS, MSc, Marzia Vezzalini, Ali Al Sayab, Maria Monne, Vinod Gupta, Govundarajulu Varadharaj, Mohamed Alsharshani, Mohamed Yassin, Claudio Sorio, MD PhD, Helmout Modjtahedi, Nader I. Al-Dewik, PhD

Blood (2018) 132 (Supplement 1): 5124.

https://doi.org/10.1182/blood-2018-99-113482

Published: 2018

Journal Articles

Active Calpain Promotes Fibrin Clot Contraction By Strengthening the Coupling of Fibrin-Bound αIIbβ3 to the Platelet Cytoskeleton

Rustem I. Litvinov, Karen Pei Yi Fong, PhD BS, Oleg V. Kim, PhD, Kathleen I. Molnar, PhD, Paul C. Billings, PhD, Alex Sternisha, BS, James A. Wells, PhD, John W. Weisel, PhD, William F. DeGrado, PhD, Joel S. Bennett, MD

Blood (2018) 132 (Supplement 1): 1128.

https://doi.org/10.1182/blood-2018-99-113063

Published: 2018

Journal Articles

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Dewen You, PhD, Victor Chatterjee, MD, Mohamed Samour, MBBS, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2385.

https://doi.org/10.1182/blood.V130.Suppl_1.2385.2385

Published: 2017

Journal Articles

Platelet Activation and Shear- dependent Changes in Filamin a Conformation Downstream of Ligand Binding to αIIbβ3, GPIb and α2β1 Are Reversible in Time, but Those Downstream of Fibrin Binding to αIIbβ3 Are Not

Barry S. Coller, MD, Claudia Buitrago, PhD

Blood (2017) 130 (Supplement 1): 1028.

https://doi.org/10.1182/blood.V130.Suppl_1.1028.1028

Published: 2017

Journal Articles

A Novel Mutant Wasp in X-Linked Neutropenia Partially Recapitulates Defective Neutrophil Production through Its Expression in WASP-Deficient NB4 Cells

Masayuki Kobayashi, MD, Bidisha Chanda, MD PhD, Muneyoshi Futami, MD PhD, Mizuho Yamashita, Mitsuhito Hirano, MD, Kazuaki Yokoyama, MD PhD, Yoichi Imai, MDPhD, Eigo Shimizu, Nozomi Yusa, Rui Yamaguchi, PhD, Seiya Imoto, PhD, Satoru Miyano, PhD, Arinobu Tojo, MD PhD

Blood (2017) 130 (Supplement 1): 3560.

https://doi.org/10.1182/blood.V130.Suppl_1.3560.3560

Published: 2017

Journal Articles

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Vijaya Pooja Vaikari, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Houda Alachkar, PhD PharmD

Blood (2016) 128 (22): 1540.

https://doi.org/10.1182/blood.V128.22.1540.1540

Published: 2016

Journal Articles

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Masaki Hayakawa, MD, Seiji Kato, PhD, Taei Matsui, PhD, Kazuya Sakai, MD, Yumi Yoshii, MD, Hideo Yagi, MD.PhD, Yoshihiro Fujimura, MD, PhD, Masanori Matsumoto, MD.PhD

Blood (2016) 128 (22): 3773.

https://doi.org/10.1182/blood.V128.22.3773.3773

Published: 2016

Journal Articles

Stable Silencing of RUNX1/ETO Induces Expression of a Shortened PU.1 Variant in t(8;21) Kasumi Cells

Matthias Eder, Caroline Schoenherr, Katharina Wohlan, Fabian Frömling, Denise Hilfiker-Kleiner, Arnold Ganser, MD, Michaela Scherr

Blood (2016) 128 (22): 2716.

https://doi.org/10.1182/blood.V128.22.2716.2716

Published: 2016

Journal Articles

Identification of Optimized Compound Combinations for the Treatment of NUP98-NSD1+ AML

Jarno Kivioja, MSc, Angeliki Thanasopoulou, PhD, Mika Kontro, MD, Bhagwan Yadav, MSc, Muntasir Mamun Majumder, MSc, Heikki Kuusanmäki, MSc, Alun Parsons, MSc, Kimmo Porkka, MD PhD, Juerg Schwaller, MD, Caroline A Heckman, PhD

Blood (2016) 128 (22): 4711.

https://doi.org/10.1182/blood.V128.22.4711.4711

Published: 2016

Journal Articles

Using Smudge Cells Percentage on Routine Blood Smear in Chronic Lymphoytic Leukemia As Prognostic Factor: Senegalese Experience

Abibatou Sall, MD, Awa Oumar Touré, MD PhD, Fatimata Bintou Sall, MD, Abdoulaye Sène, PharmD, Cedric Aumont, PharmD, Moussa Seck, MD, Blaise Félix Faye, MD, Tandakha Ndiaye Dièye, PharmD, PhD, Saliou Diop, MD MSC, Sophie Reynaud, MD PhD, Martine Raphaël, MD PhD

Blood (2015) 126 (23): 5273.

https://doi.org/10.1182/blood.V126.23.5273.5273

Published: 2015

Journal Articles

Differential Signaling through p190 and p210 Forms of BCR-ABL Fusion Proteins Revealed By Proteomic Analysis

Jevon Cutler, Rahia Tahir, Jingnan Han, Raja Sekhar Nirujogi, Tai-Chung Huang, MD, Xianrong Wong, Saradhi Mallampati, Xiaoping Sun, MD PhD, Patrick Brown, MD, Karen Reddy, PhD, Akhilesh Pandey, MD PhD

Blood (2015) 126 (23): 3651.

https://doi.org/10.1182/blood.V126.23.3651.3651

Published: 2015

Journal Articles

GADD45a Is a Tumor Suppressor in BCR-ABL-Driven Leukemogenesis

Kaushiki Mukherjee, Xiaojin Sha, MD PhD, Tomasz Skorski, MD PhD, Ravi Bhatia, MD, Barbara Hoffman, PhD, Dan Liebermann, PhD

Blood (2014) 124 (21): 4530.

https://doi.org/10.1182/blood.V124.21.4530.4530

Published: 2014

Journal Articles

MLL-Rearranged Infant ALL, but Not Standard-Risk ALL, Induces Inflammasome Signaling and Immune Activation

Jessica C Shand, MD, Jinno Magno, Michael Weinstein Winter, MD, Liana M Toia

Blood (2014) 124 (21): 3660.

https://doi.org/10.1182/blood.V124.21.3660.3660

Published: 2014

Journal Articles

Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 829.

https://doi.org/10.1182/blood.V124.21.829.829

Published: 2014

Journal Articles

The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph+ Acute Lymphoblastic Leukemia

Gunhan Gurman, MD, Mustafa Merter, MD, Pinar Ataca, MD, Mehmet Ozen, MD, Berna Atesagaoglu, MD, Mehmet Gunduz, MD, Gultekin Pekcan, MD, Ugur Sahin, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Osman Ilhan, MD, Erden Atilla, MD

Blood (2014) 124 (21): 5281.

https://doi.org/10.1182/blood.V124.21.5281.5281

Published: 2014

Journal Articles

Egr-1, a Stress Response Transcription Factor and Myeloid Differentiation Primary Response Gene, Behaves As Tumor Suppressor in CML

Silvia Maifrede, PhDcandidate, Dan Liebermann, PhD, Barbara Hoffman, PhD

Blood (2014) 124 (21): 2211.

https://doi.org/10.1182/blood.V124.21.2211.2211

Published: 2014

Journal Articles

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

Bing Cui, Liguang Chen, Suping Zhang, Marek Mraz, Jessie-F. Fecteau, Jian Yu, Emanuela M. Ghia, Ling Zhang, Lei Bao, Laura Z. Rassenti, Karen Messer, George A. Calin, Carlo M. Croce, Thomas J. Kipps

Blood (2014) 124 (4): 546–554.

https://doi.org/10.1182/blood-2014-03-559690

Published: 2014

Includes: Supplemental data

Journal Articles

GADD45a Is a Tumor Suppressor In BCR-ABL-Driven Leukemogenesis

Kaushiki Mukherjee, Xiaojin Sha, MD, PhD, Ravi Bhatia, MD, Tomasz Skorski, MD, PhD, Barbara Hoffman, PhD, Dan Liebermann

Blood (2013) 122 (21): 1467.

https://doi.org/10.1182/blood.V122.21.1467.1467

Published: 2013

NARROW

CircPCMTD1 : A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts

Cooperation between SYK and ZAP70 Kinases As a Driver of Oncogenic BCR-Signaling in B-Cell Malignancies

Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar

Active Calpain Promotes Fibrin Clot Contraction By Strengthening the Coupling of Fibrin-Bound αIIbβ3 to the Platelet Cytoskeleton

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Platelet Activation and Shear- dependent Changes in Filamin a Conformation Downstream of Ligand Binding to αIIbβ3, GPIb and α2β1 Are Reversible in Time, but Those Downstream of Fibrin Binding to αIIbβ3 Are Not

A Novel Mutant Wasp in X-Linked Neutropenia Partially Recapitulates Defective Neutrophil Production through Its Expression in WASP-Deficient NB4 Cells

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Stable Silencing of RUNX1/ETO Induces Expression of a Shortened PU.1 Variant in t(8;21) Kasumi Cells

Identification of Optimized Compound Combinations for the Treatment of NUP98-NSD1+ AML

Using Smudge Cells Percentage on Routine Blood Smear in Chronic Lymphoytic Leukemia As Prognostic Factor: Senegalese Experience

Differential Signaling through p190 and p210 Forms of BCR-ABL Fusion Proteins Revealed By Proteomic Analysis

GADD45a Is a Tumor Suppressor in BCR-ABL-Driven Leukemogenesis

MLL-Rearranged Infant ALL, but Not Standard-Risk ALL, Induces Inflammasome Signaling and Immune Activation

Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia

The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph+ Acute Lymphoblastic Leukemia

Egr-1, a Stress Response Transcription Factor and Myeloid Differentiation Primary Response Gene, Behaves As Tumor Suppressor in CML

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

GADD45a Is a Tumor Suppressor In BCR-ABL-Driven Leukemogenesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only